Citations (90)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Koju Kamoi. (2023) Current challenges facing the clinical treatment for HTLV-1 ocular manifestations. Expert Review of Ophthalmology 0:0, pages 1-15.
Read now
Read now
Elisa Camela, Luca Potestio, Gabriella Fabbrocini & Matteo Megna. (2022) Paradoxical reactions to biologicals for psoriasis. Expert Opinion on Biological Therapy 22:12, pages 1435-1437.
Read now
Read now
David R. Jordan, John S. Y. Park & Danah Al-Breiki. (2022) Acute orbital inflammation with loss of vision: a paradoxical adverse event associated with infliximab therapy for Crohn’s disease. Orbit 41:6, pages 791-796.
Read now
Read now
Francesca Marino, Salvatore D’Angelo, Ignazio Francesco Masala, Elisabetta Gerratana, Valeria Nucera, Laura La Corte, Manuela Giallanza, Piercarlo Sarzi-Puttini & Fabiola Atzeni. (2020) Toxicological considerations in the treatment of axial spondylo-arthritis. Expert Opinion on Drug Metabolism & Toxicology 16:8, pages 663-672.
Read now
Read now
Richard Melsheimer, Anja Geldhof, Isabel Apaolaza & Thomas Schaible. (2019) Remicade® (infliximab): 20 years of contributions to science and medicine. Biologics: Targets and Therapy 13, pages 139-178.
Read now
Read now
Fabio Salvatore Macaluso, Ambrogio Orlando & Mario Cottone. (2019) Anti-interleukin-12 and anti-interleukin-23 agents in Crohn’s disease. Expert Opinion on Biological Therapy 19:2, pages 89-98.
Read now
Read now
Salvatore D’Angelo, Antonio Carriero, Michele Gilio, Francesco Ursini, Pietro Leccese & Carlo Palazzi. (2018) Safety of treatment options for spondyloarthritis: a narrative review. Expert Opinion on Drug Safety 17:5, pages 475-486.
Read now
Read now
Xavier Guillot, Clément Prati, Maxime Sondag & Daniel Wendling. (2017) Etanercept for treating axial spondyloarthritis. Expert Opinion on Biological Therapy 17:9, pages 1173-1181.
Read now
Read now
Daniel Wendling, Frank Verhoeven, Xavier Guillot & Clément Prati. (2017) Immunogenicity of TNF alpha inhibitors in rheumatology: many questions, enough answers?. Expert Opinion on Drug Safety 16:1, pages 1-3.
Read now
Read now
Marine Delobeau, Ahlam Abdou, Eve Puzenat, Elise Deveza, Caroline Biver-Dalle, Alison van de Laak, Blandine Roche-Kubler, Lucine Vuitton, Stéphane Koch, Daniel Wendling & François Aubin. (2016) Observational case series on adalimumab-induced paradoxical hidradenitis suppurativa. Journal of Dermatological Treatment 27:3, pages 251-253.
Read now
Read now
Rik J Lories & Kurt de Vlam. (2014) Tumour necrosis factor inhibitors in the treatment of psoriatic arthritis: a view on effectiveness, clinical practice and toxicity. Expert Opinion on Biological Therapy 14:12, pages 1825-1836.
Read now
Read now
Daniel Wendling, Avani Joshi, Patrick Reilly, Yash J. Jalundhwala, Manish Mittal & Yanjun Bao. (2014) Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis: an analysis of a large US claims database. Current Medical Research and Opinion 30:12, pages 2515-2521.
Read now
Read now
Hubert Marotte & Rolando Cimaz. (2014) Etanercept – TNF receptor and IgG1 Fc fusion protein: is it different from other TNF blockers?. Expert Opinion on Biological Therapy 14:5, pages 569-572.
Read now
Read now
Articles from other publishers (77)
Ioana Ruxandra Mihai, Alexandra Maria Burlui, Ioana Irina Rezus, Cătălina Mihai, Luana Andreea Macovei, Anca Cardoneanu, Otilia Gavrilescu, Mihaela Dranga & Elena Rezus. (2023) Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-α Treatment—A Review. Life 13:8, pages 1779.
Crossref
Crossref
Stefanie Luecke, Adewunmi Adelaja, Xiaolu Guo, Supriya Sen, Roberto Spreafico, Apeksha Singh, Yi Liu, Brooks Taylor, Jessica Diaz, Quen Cheng & Alexander Hoffmann. (2023)
Tonic
TNF
conditioning of macrophages safeguards stimulus‐specific inflammatory responses
. EMBO reports 24:7.
Crossref
Crossref
Hiroaki Okuda, Shuhei Hosomi, Shigehiro Itani, Noriyuki Kurimoto, Yumie Kobayashi, Rieko Nakata, Yu Nishida, Masaki Ominami, Yuji Nadatani, Shusei Fukunaga, Koji Otani, Noriko Kamata, Fumio Tanaka, Yasuaki Nagami, Koichi Taira, Satoko Ohfuji & Yasuhiro Fujiwara. (2023) Pretreatment serum monocyte chemoattractant protein‐1 as a predictor of long‐term outcome by ustekinumab in patients with Crohn's disease. Journal of Gastroenterology and Hepatology 38:6, pages 910-920.
Crossref
Crossref
N. Collongues, R. Felten, J. De Seze & K. Bigaut. (2023) Gestione delle bioterapie ad uso dei neurologi. EMC - Neurologia 23:2, pages 1-19.
Crossref
Crossref
Pedro Bernardo Santos, Maria Manuela Loureiro & Anabela Barcelos. (2023) A Rare Case of Subcutaneous Sarcoidosis in Patient With Psoriatic Arthritis. The Journal of Rheumatology 50:1, pages 148-149.
Crossref
Crossref
Ana De Vicente Delmás, Lara Sanchez-Bilbao, Vanesa Calvo-Río, David Martínez-López, Alba Herrero-Morant, Eva Galíndez-Agirregoikoa, Iñigo Gonzalez-Mazon, Nuria Barroso-García, Natalia Palmou-Fontana, Miguel A Gonzalez-Gay, José L Hernández & Ricardo Blanco. (2023) Uveitis in psoriatic arthritis: study of 406 patients in a single university center and literature review. RMD Open 9:1, pages e002781.
Crossref
Crossref
Pauline Bataille, Richard Layese, Pascal Claudepierre, Nicolas Paris, Julien Dubiel, Aurélien Amiot & Emilie Sbidian. (2022) Paradoxical reactions and biologic agents: a French cohort study of 9303 patients. British Journal of Dermatology 187:5, pages 676-683.
Crossref
Crossref
L.L. Tirelli, A. Alfaro, G. Citera & C.M. Echeverría. (2022) [Articulo traducio] Alopecia no cicatricial secundaria a secukinumab. Actas Dermo-Sifiliográficas 113:10, pages T1011-T1013.
Crossref
Crossref
L.L. Tirelli, A. Alfaro, G. Citera & C.M. Echeverría. (2022) Nonscarring Alopecia Secondary to Secukinumab. Actas Dermo-Sifiliográficas 113:10, pages 1011-1013.
Crossref
Crossref
Guan-Yu Wang, Dong Shang, Gui-Xin Zhang, Hui-Yi Song, Nan Jiang, Huan-Huan Liu & Hai-Long Chen. (2022)
Qingyi decoction attenuates intestinal epithelial cell injury
via
the calcineurin/nuclear factor of activated T-cells pathway
. World Journal of Gastroenterology 28:29, pages 3825-3837.
Crossref
Crossref
Yuliya Lytvyn, Asfandyar Mufti, Khalad Maliyar, Muskaan Sachdeva & Jensen Yeung. (2022) Onset of Pyoderma Gangrenosum in Patients on Biologic Therapies: A Systematic Review. Advances in Skin & Wound Care 35:8, pages 454-460.
Crossref
Crossref
Diana Alexandra Gonçalves Pimenta, Leonor Meira, Rui Rolo & Lurdes Ferreira. (2022) Sarcoidosis-like reaction secondary to adalimumab treatment in a patient with axial spondyloarthritis. Monaldi Archives for Chest Disease.
Crossref
Crossref
Büşra Köse, Dilek Uzlu & Hidayet Erdöl. (2022) Psoriasis and uveitis. International Ophthalmology 42:7, pages 2303-2310.
Crossref
Crossref
Mana USUI, Emi YOKOYAMA, Osamu YAMASAKI, Takayuki KATSUYAMA, Miyuki KOSOGABE, Yoshinori SHIRAFUJI & Shin MORIZANE. (2022) Two Cases of Rheumatoid Arthritis with Cuataneous Leukocytoclastic Vasculitis Induced by Tocilizumabトシリズマブ投与後に皮膚白血球破砕性血管炎がみられた関節リウマチの 2 例. Nishi Nihon Hifuka 84:3, pages 202-206.
Crossref
Crossref
Koju Kamoi, Toshiki Watanabe, Kaoru Uchimaru, Akihiko Okayama, Seiko Kato, Toyotaka Kawamata, Hisako Kurozumi-Karube, Noe Horiguchi, Yuan Zong, Yoshihisa Yamano, Isao Hamaguchi, Yasuhito Nannya, Arinobu Tojo & Kyoko Ohno-Matsui. (2022) Updates on HTLV-1 Uveitis. Viruses 14:4, pages 794.
Crossref
Crossref
Yi Guo, Ke Hu, Yuxuan Li, Chanjun Lu, Ken Ling, Chuanqi Cai, Weici Wang & Dawei Ye. (2022) Targeting TNF-α for COVID-19: Recent Advanced and Controversies. Frontiers in Public Health 10.
Crossref
Crossref
Spyridon Gkalpakiotis, Marketa Fridman & Simona Tivadar. (2022) Adalimumab Biosimilar-Induced Severe Paradoxical Palmoplantar Pustulosis in a Patient with Psoriasis and Psoriatic Arthritis Successfully Treated with Ixekizumab. Dermatology and Therapy 12:2, pages 605-609.
Crossref
Crossref
Guanyu Wang, Dong Shang, Guixin Zhang, Shenglin Zhang, Nan Jiang, Huanhuan Liu & Hailong Chen. (2022) Effects of QingYi decoction on inflammatory markers in patients with acute pancreatitis: A meta-analysis. Phytomedicine 95, pages 153738.
Crossref
Crossref
A. P. Bewley & S. Maleki. (2021) Systemic sarcoidosis reactions as a result of tumour necrosis factor‐alpha treatment for patients with psoriasis. Clinical and Experimental Dermatology 46:8, pages 1548-1550.
Crossref
Crossref
Caroline Ngoufack, Luca Semerano, Isabelle Podglajen, Patrick Bruneval, Christophe Meune, Dominique Valeyre, Robin Dhote, Marie-Christophe Boissier & Nathalie Saidenberg-Kermanac’h. (2021) Granulomatose de la valve mitrale : un cas de réaction paradoxale compliquant un traitement par étanercept au cours d’une polyarthrite rhumatoïde. Revue du Rhumatisme 88:6, pages 459-462.
Crossref
Crossref
Susumu Fukahori, Yasushi Obase, Chizu Fukushima, Daisuke Takao, Jun Iriki, Mutsumi Ozasa, Yoshiaki Zaizen, Noboru Takamura, Junya Fukuoka, Kazuto Ashizawa & Hiroshi Mukae. (2021) Determining Response to Treatment for Drug-Induced Bronchocentric Granulomatosis by the Forced Oscillation Technique. Medicina 57:12, pages 1315.
Crossref
Crossref
Miho Mori, Rie Tobita, Chizu Egusa, Tatsuo Maeda, Namiko Abe, Hiroshi Kawakami, Kenichiro Mae, Yuka Matsumoto, Yasuhiro Kawachi & Yukari Okubo. (2021) Clinical background of patients with psoriasiform skin lesions due to tumor necrosis factor antagonist administration at a single center. The Journal of Dermatology 48:11, pages 1745-1753.
Crossref
Crossref
Carla Isabelly Rodrigues-Fernandes, Cesar Augusto Migliorati, Luiz Alcino Monteiro Gueiros, Thayná Melo de Lima Morais, Pablo Agustin Vargas, Oslei Paes de Almeida, Márcio Ajudarte Lopes & Alan Roger Santos-Silva. (2021) Adalimumab-induced sarcoidosis-like reaction involving oral cavity in rheumatoid arthritis: a case-based review. Clinical Rheumatology 40:9, pages 3833-3839.
Crossref
Crossref
Caroline Ngoufack, Luca Semerano, Isabelle Podglajen, Patrick Bruneval, Christophe Meune, Dominique Valeyre, Robin Dhote, Marie-Christophe Boissier & Nathalie Saidenberg-Kermanac’h. (2021) Mitral valve granulomatosis: A paradoxical reaction complicating etanercept treatment in rheumatoid arthritis. A case report. Joint Bone Spine 88:4, pages 105183.
Crossref
Crossref
Martina Morelli, Claudia Scarponi, Stefania Madonna & Cristina Albanesi. 2021. The TNF Superfamily. The TNF Superfamily
155
165
.
Hisako Kurozumi-Karube, Koju Kamoi, Naoko Ando, Minami Uchida, Isao Hamaguchi & Kyoko Ohno-Matsui. (2020) In vitro Evaluation of the Safety of Adalimumab for the Eye Under HTLV-1 Infection Status: A Preliminary Study. Frontiers in Microbiology 11.
Crossref
Crossref
Margaret M. Lowe, Haley B. Naik, Sean Clancy, Mariela Pauli, Kathleen M. Smith, Yingtao Bi, Robert Dunstan, Johann E. Gudjonsson, Maia Paul, Hobart Harris, Esther Kim, Uk Sok Shin, Richard Ahn, Wilson Liao, Scott L. Hansen & Michael D. Rosenblum. (2020) Immunopathogenesis of hidradenitis suppurativa and response to anti–TNF-α therapy. JCI Insight 5:19.
Crossref
Crossref
Ilaria Floris, Thorsten Rose, Juan Antonio Collado Rojas, Kurt Appel, Camille Roesch & Beatrice Lejeune. (2020) Pro-Inflammatory Cytokines at Ultra-Low Dose Exert Anti-Inflammatory Effect In Vitro: A Possible Mode of Action Involving Sub-Micron Particles?. Dose-Response 18:4, pages 155932582096172.
Crossref
Crossref
Marine Fauny, David Moulin, Ferdinando D'Amico, Patrick Netter, Nadine Petitpain, Djesia Arnone, Jean-Yves Jouzeau, Damien Loeuille & Laurent Peyrin-Biroulet. (2020) Paradoxical gastrointestinal effects of interleukin-17 blockers. Annals of the Rheumatic Diseases 79:9, pages 1132-1138.
Crossref
Crossref
F. Cohen Aubart, R. Lhote, A. Amoura, D. Valeyre, J. Haroche, Z. Amoura & B. Lebrun‐Vignes. (2019) Drug‐induced sarcoidosis: an overview of the WHO pharmacovigilance database. Journal of Internal Medicine 288:3, pages 356-362.
Crossref
Crossref
Chayada Chaiyabutr, Patompong Ungprasert, Narumol Silpa-archa, Chanisada Wongpraparut & Leena Chularojanamontri. (2020) Psoriasis and Risk of Uveitis: A Systematic Review and Meta-Analysis. BioMed Research International 2020, pages 1-8.
Crossref
Crossref
Masataka Satoh & Toshiyuki Yamamoto. (2020) Secukinumab‐induced palmar vesiculopustular eruption in a patient with psoriasis. Dermatologic Therapy 33:3.
Crossref
Crossref
Xia Ni Wu, Lazha Ahmed Talat Sharief, Roy Schwartz, Þóra Elísabet Jónsdóttir, Anastasia Tasiopoulou, Ahmed Al-Janabi, Noura Al Qassimi, Amgad Mahmoud, Sue Lightman & Oren Tomkins-Netzer. 2020. Current Concepts in Ophthalmology. Current Concepts in Ophthalmology
121
140
.
Luca Fania, Martina Morelli, Claudia Scarponi, Laura Mercurio, Fernanda Scopelliti, Caterina Cattani, Giovanni Luca Scaglione, Tiziano Tonanzi, Maria Antonietta Pilla, Gianluca Pagnanelli, Cinzia Mazzanti, Giampiero Girolomoni, Andrea Cavani, Stefania Madonna & Cristina Albanesi. (2019) Paradoxical psoriasis induced by TNF‐α blockade shows immunological features typical of the early phase of psoriasis development. The Journal of Pathology: Clinical Research 6:1, pages 55-68.
Crossref
Crossref
Greg Koller, Jill Hall & Carrie Ye. (2019) Response: Leflunomide: potential treatment and cause of alopecia areata. Clinical Rheumatology 38:10, pages 2959-2961.
Crossref
Crossref
Minami Uchida, Koju Kamoi, Naoko Ando, Chenxi Wei, Hisako Karube & Kyoko Ohno-Matsui. (2019) Safety of Infliximab for the Eye Under Human T-Cell Leukemia Virus Type 1 Infectious Conditions in vitro. Frontiers in Microbiology 10.
Crossref
Crossref
Chiharu Iwahashi, Hikari Ono, Mami Haruta, Takamasa Minami, Hisashi Mashimo, Hiroshi Shimojo & Nobuyuki Ohguro. (2019) New onset or exacerbation of uveitis with infliximab: paradoxical effects?. BMJ Open Ophthalmology 4:1, pages e000250.
Crossref
Crossref
Benedicta Nneoma Nnodum, Lida P. Hariri, Despoina Mavrommati & Lauren Dudley. (2019) A Case of Severe Symptomatic Central Nervous System Sarcoidosis Secondary to Treatment with Adalimumab. Case Reports in Rheumatology 2019, pages 1-6.
Crossref
Crossref
Döndü Üsküdar Cansu, Hava Üsküdar Teke, Tuncer Temel, Adem Ertürk, Osman Kahraman & Cengiz Korkmaz. (2019) Do Anti-TNF Agents Increase the Risk of Inflammatory Bowel Disease Evolution in Patients with Ankylosing Spondylitis? Real Life Data. Journal of the National Medical Association 111:3, pages 262-269.
Crossref
Crossref
Daniel Wendling. (2019) New targeted therapies in spondyloarthritis: what are the limits?. Immunotherapy 11:7, pages 557-560.
Crossref
Crossref
Danielle Hutchings, James A. Miller & Lysandra Voltaggio. (2019) Paradoxical gastrointestinal reactions in patients taking tumor necrosis factor inhibitors: a rare event that broadens the histologic spectrum of medication–associated injury. Human Pathology 85, pages 202-209.
Crossref
Crossref
Jean-Luc Davignon, Benjamin Rauwel, Yannick Degboé, Arnaud Constantin, Jean-Fredéric Boyer, Andrey Kruglov & Alain Cantagrel. (2018) Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review. Arthritis Research & Therapy 20:1.
Crossref
Crossref
Maxime Sondag, Frank Verhoeven, Xavier Guillot, Clément Prati, Charline Briot, Lucine Vuitton, Stéphane Koch & Daniel Wendling. (2018) Arthralgies « paradoxales » développées sous anti-TNF-α chez des patients suivis pour une maladie inflammatoire chronique de l’intestin. Revue du Rhumatisme 85:6, pages 597-599.
Crossref
Crossref
Arianna Zangrilli, Mauro Bavetta, Sara Mazzilli, Virginia Garofalo & Luca Bianchi. (2018) Paradoxical case effects of psoriasis following adalimumab therapy: A case series. Dermatologic Therapy 31:6, pages e12729.
Crossref
Crossref
Alexander Nelson, Christina Cunha, Michael I. Nishimura & Makio Iwashima. (2018) Activated human Foxp3+ regulatory T cells produce membrane-bound TNF. Cytokine 111, pages 454-459.
Crossref
Crossref
Martina Biggioggero, Chiara Crotti, Andrea Becciolini, Elisabetta Miserocchi & Ennio Giulio Favalli. (2018) The Management of Acute Anterior Uveitis Complicating Spondyloarthritis: Present and Future. BioMed Research International 2018, pages 1-11.
Crossref
Crossref
William Terreaux, Claire Masson, Jean-Paul Eschard, Thomas Bardin, Arnaud Constantin, Loïc Le Dantec, Christian Marcelli, Aleth Perdriger, Claire Scotto Di Fazano, Daniel Wendling, Jean Sibilia, Jacques Morel & Jean-Hugues Salmon. (2018) Incidence des réactions paradoxales chez les patients traités par tocilizumab pour une polyarthrite rhumatoïde : données du registre français REGATE. Revue du Rhumatisme 85:5, pages 479-483.
Crossref
Crossref
Min Jung Kim, Eunyoung Emily Lee, Eun Young Lee, Yeong Wook Song, Hyeong Gon Yu, Yunhee Choi & Eun Bong Lee. (2018) Preventive effect of tumor necrosis factor inhibitors versus nonsteroidal anti-inflammatory drugs on uveitis in patients with ankylosing spondylitis. Clinical Rheumatology 37:10, pages 2763-2770.
Crossref
Crossref
M.J. Gooderham, K.A. Papp & C.W. Lynde. (2018) Shifting the focus - the primary role of IL-23 in psoriasis and other inflammatory disorders. Journal of the European Academy of Dermatology and Venereology 32:7, pages 1111-1119.
Crossref
Crossref
Alessandro Armuzzi, Sandro Ardizzone, Livia Biancone, Fabiana Castiglione, Silvio Danese, Paolo Gionchetti, Ambrogio Orlando, Fernando Rizzello, Maria Lia Scribano, Maurizio Vecchi & Marco Daperno. (2018) Ustekinumab in the management of Crohn’s disease: Expert opinion. Digestive and Liver Disease 50:7, pages 653-660.
Crossref
Crossref
Sophie Steeland, Claude Libert & Roosmarijn E. Vandenbroucke. (2018) A New Venue of TNF Targeting. International Journal of Molecular Sciences 19:5, pages 1442.
Crossref
Crossref
Massimo Cugno, Roberta Gualtierotti, Pier Luigi Meroni & Angelo Valerio Marzano. (2017) Inflammatory Joint Disorders and Neutrophilic Dermatoses: a Comprehensive Review. Clinical Reviews in Allergy & Immunology 54:2, pages 269-281.
Crossref
Crossref
Edouard Louis. (2018) Stopping Biologics in IBD—What Is the Evidence?. Inflammatory Bowel Diseases 24:4, pages 725-731.
Crossref
Crossref
Karolína Vorčáková, Péč Juraj, Péčová Tatiana & Martinásková Klára. 2018. Antibody Engineering. Antibody Engineering.
William Terreaux, Claire Masson, Jean-Paul Eschard, Thomas Bardin, Arnaud Constantin, Loïc Le Dantec, Christian Marcelli, Aleth Perdriger, Claire Scotto Di Fazano, Daniel Wendling, Jean Sibilia, Jacques Morel & Jean-Hugues Salmon. (2018) Incidence of paradoxical reactions in patients treated with tocilizumab for rheumatoid arthritis: Data from the French registry REGATE. Joint Bone Spine 85:1, pages 53-57.
Crossref
Crossref
Maxime Sondag, Frank Verhoeven, Xavier Guillot, Clément Prati, Charline Briot, Lucine Vuitton, Stéphane Koch & Daniel Wendling. (2018) “Paradoxical” arthralgia occurring under anti-TNFα treatment for inflammatory bowel disease. Joint Bone Spine 85:1, pages 133-134.
Crossref
Crossref
Roberta Gualtierotti, Angelo Valerio Marzano & Massimo Cugno. 2018. Neutrophilic Dermatoses. Neutrophilic Dermatoses
247
258
.
Olivier Dereure & William Camu. (2017) Teriflunomide-induced psoriasiform changes of fingernails: a new example of paradoxical side effect?. International Journal of Dermatology 56:12, pages 1479-1481.
Crossref
Crossref
P. Korsten & G. Chehab. (2017) Muskuloskelettale Manifestationen der SarkoidoseMusculoskeletal manifestations of sarcoidosis. Zeitschrift für Rheumatologie 76:5, pages 408-414.
Crossref
Crossref
Vincenzo Bruzzese, Vincenzo De Francesco, Cesare Hassan, Roberto Lorenzetti, Palma Scolieri, Cinzia Marrese & Angelo Zullo. (2017) New onset or worsening of psoriasis following biologic therapy: A case series. International Journal of Immunopathology and Pharmacology 30:1, pages 70-72.
Crossref
Crossref
M. Revenga Martínez, M.A. Blázquez Cañamero & M. Llop Vilatella. (2017) Sarcoidosis. Medicine - Programa de Formación Médica Continuada Acreditado 12:27, pages 1560-1573.
Crossref
Crossref
J.F. Mir-Bonafe, A. Lopez-Ferrer, A. Laiz & L. Puig. (2017) Triple paradoxical reaction due to adalimumab. Journal of the European Academy of Dermatology and Venereology 31:2, pages e71-e73.
Crossref
Crossref
Kyle Amber & Michael Hertl. 2017. Clinical and Basic Immunodermatology. Clinical and Basic Immunodermatology
767
774
.
Marcus Zulian Teixeira. (2016) Biological therapies (immunomodulatory drugs), worsening of psoriasis and rebound effect: new evidence of similitude. Homeopathy 105:4, pages 344-355.
Crossref
Crossref
Yuan-Zheng Yang, Ying Xiang, Mian Chen, Li-Na Xian & Xiao-Yan Deng. (2016) Clinical significance of dynamic detection for serum levels of MCP-1, TNF-α and IL-8 in patients with acute pancreatitis. Asian Pacific Journal of Tropical Medicine 9:11, pages 1111-1114.
Crossref
Crossref
W. Terreaux, C. Masson, J.-P. Eschard, T. Bardin, A. Constantin, L. Le Dantec, C. Marcelli, A. Perdriger, C. Scotto Di Fazano, D. Wendling, J. Sibilia, J. Morel & J.H. Salmon. (2016) Incidence des effets paradoxaux survenant chez les patients ayant une polyarthrite rhumatoïde sous tocilizumab : données du registre français REGATE. Revue du Rhumatisme 83, pages A48-A49.
Crossref
Crossref
Amelie Decock, Gert Van Assche, Séverine Vermeire, Wim Wuyts & Marc Ferrante. (2016) Sarcoidosis-Like Lesions: Another Paradoxical Reaction to Anti-TNF Therapy?. Journal of Crohn's and Colitis, pages jjw155.
Crossref
Crossref
T Cabaleiro, R Prieto-Pérez, R Navarro, G Solano, M Román, D Ochoa, F Abad-Santos & E Daudén. (2015) Paradoxical psoriasiform reactions to anti-TNFα drugs are associated with genetic polymorphisms in patients with psoriasis. The Pharmacogenomics Journal 16:4, pages 336-340.
Crossref
Crossref
Jung Eun SeolIn Ho ParkWonkyung LeeHyojin KimSo Young JungHan Young Wang. (2016) Palmoplantar Pustulosis Induced by both Adalimumab and Golimumab for Treatment of Ankylosing Spondylitis. Annals of Dermatology 28:4, pages 522.
Crossref
Crossref
Misa Hirose, Anika Kasprick, Foteini Beltsiou, Katharina Schulze Dieckhoff, Franziska Sophie Schulze, Unni K J S R L Samavedam, Jennifer E Hundt, Hendri H Pas, Marcel F Jonkman, Enno Schmidt, Kathrin Kalies, Detlef Zillikens, Ralf J Ludwig & Katja Bieber. (2016) Reduced Skin Blistering in Experimental Epidermolysis Bullosa Acquisita After Anti-TNF Treatment. Molecular Medicine 22:1, pages 918-926.
Crossref
Crossref
Minyoung Her & Arthur Kavanaugh. (2016) Alterations in immune function with biologic therapies for autoimmune disease. Journal of Allergy and Clinical Immunology 137:1, pages 19-27.
Crossref
Crossref
Anne-Sophie Soubrier, Peggy Bele-Philippe, Bernard Cortet, Nassima Ramdane-Sebbane, Marie-Astrid Bacle-Boutry, Lucie Lemeunier, Rene-Marc Flipo & Julien Paccou. (2015) Réponse au traitement, maintien thérapeutique et tolérance des anti-tumour necrosis factor α chez 193 patients atteints de rhumatisme psoriasique : une expérience de 12ans dans la « vraie vie ». Revue du Rhumatisme 82:2, pages 99-105.
Crossref
Crossref
Hiroki Kiyohara, Tadakazu Hisamatsu, Katsuyoshi Matsuoka, Makoto Naganuma, Hideto Kameda, Noriyuki Seta, Tsutomu Takeuchi & Takanori Kanai. (2015) Crohn's Disease in which the Patient Developed Aortitis during Treatment with Adalimumab. Internal Medicine 54:14, pages 1725-1732.
Crossref
Crossref
Daniel Wendling, Xavier Guillot & Clément Prati. (2015) The IL-23/Th 17 pathway in spondyloarthritis: The Royal Road?. Joint Bone Spine 82:1, pages 1-4.
Crossref
Crossref
Anne-Sophie Soubrier, Peggy Bele-Philippe, Bernard Cortet, Nassima Ramdane-Sebbane, Marie-Astrid Bacle-Boutry, Lucie Lemeunier, Rene-Marc Flipo & Julien Paccou. (2015) Treatment response, drug survival and safety of anti-tumour necrosis factor α therapy in 193 patients with psoriatic arthritis: A twelve-year “real life” experience. Joint Bone Spine 82:1, pages 31-37.
Crossref
Crossref
Daniel Wendling, Xavier Guillot & Clément Prati. (2014) L’axe IL-23/Th17 dans la spondyloarthrite : la voie royale ?. Revue du Rhumatisme 81:6, pages 447-450.
Crossref
Crossref
Usman Khalid, Gunnar Hilmar Gislason & Peter Riis Hansen. (2014) Sarcoidosis in Patients with Psoriasis: A Population-Based Cohort Study. PLoS ONE 9:10, pages e109632.
Crossref
Crossref